Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients
P Housset, Anne‐Laure Faucon(Karolinska Institutet), Nathalie Vittoz, Sabah Kubab, Agathe Pardon, Latifa Hanafi, Valérie Caudwell, Dogan-Firat Bozman
Cited by 15
Related Papers
Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies
|European Journal of Radiology|2019|149
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
|American Journal of Kidney Diseases|2021|136
Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease
|European Heart Journal|2024|68
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
|Nephrology Dialysis Transplantation|2023|60